Lactams for treatment of CNS disorders

Details for Australian Patent Application No. 2004291296 (hide)

Owner Glaxo Group Limited

Inventors Di Fabio, Romano; Mattioli, Lucia; Giovannini, Riccardo; Paio, Alfredo; Alvaro, Giuseppe; Tranquillini, Maria Elvira

Agent Davies Collison Cave

Pub. Number AU-B-2004291296

PCT Pub. Number WO2005/049600

Priority 0326407.4 12.11.03 GB

Filing date 10 November 2004

Wipo publication date 2 June 2005

Acceptance publication date 7 April 2011

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

11 May 2006 PCT application entered the National Phase

  PCT publication WO2005/049600 Priority application(s): WO2005/049600

7 April 2011 Application Accepted

  Published as AU-B-2004291296

4 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004291297-Novel piperidine-substituted indolesor heteroderivatives thereof

2004291287-Solid molded polycarbonate member having improved optical and processing characteristics